Our experiment confirmed the prognostic significance of PD-1 protein level, and further validated the hypothesis that the PD-1/PD-L1 pathway played a negative role in tumour immunity in pancreatic cancer. The gene discussed is CD274; the disease is familial pancreatic carcinoma.